MarketPlace Logan Announces New XpresCheck™ COVID-19 Testing Facility at Boston Logan International Airport

BOSTON, MA – October 15, 2020 – MarketPlace Logan, an affiliate of Boston-based New England Development and manager of the Boston Logan Concessions’ Program (BOS SHOP DINE) announced today that XpresSpa Group’s new XpresCheck™ COVID-19 testing facility will open and be fully operational by mid November at Boston Logan International Airport.

XpresCheck COVID-19 testing facility at Boston Logan is a modular constructed facility within the International Arrival area in Terminal E (pre-security), and is expected to host seven separate testing rooms with an anticipated ability to administer over 400 tests per day for passengers arriving and departing the airport within all terminals, as well as airport employees. There are three COVID-19 testing options offered including a rapid molecular COVID-19 test, the Polymerase Chain Reaction (PCR) Test, and the Blood Antibody Test.

“We continue to explore new ways to expand on preventative measures and new technology that we have implemented to ensure the health and safety of our passengers and employees. The COVID-19 testing site in Terminal E is another example of that commitment. We strongly believe that the quick and easily accessible testing site will provide travelers a further sense of security as they travel through Boston Logan,” said Paul McGinn, President of MarketPlace Development.

Airport employees and travelers alike can visit the XpresCheck via walk-in appointments or by scheduling in advance. Pricing varies, $75.00 for an individual PCR Test or individual Blood Antibody Test, $90.00 for both (the PCR Test and Blood Antibody Test), $200.00 for the rapid molecular COVID-19 test, or $215.00 for the rapid molecular COVID-19 test plus additional tests offered. XpresCheck also accepts insurance for the individual PCR and Blood Antibody Test. The entire testing process which involves introductions, administering the test, and the clinical visit takes up to approximately 20 minutes and results are provided onsite if having the rapid molecular COVID-19 test or shared via XpresCheck’s secure patient portal.

“We are eager to launch XpresCheck at Boston Logan International Airport, which is our third COVID-19 testing facility in the country. We believe that our presence at Boston Logan enables us to play an important role in supporting the return of domestic and international air travel to pre-pandemic levels by making sure both airport employees and travelers feel safe and confident when they come to the airport,” said, Doug Satzman, CEO of XpresSpa.

Travelers looking to make an appointment in advance for a more contactless experience can log onto XpresCheck’s website at  XpresCheck is open Monday through Friday from 10:00 a.m. – 6:00 p.m.

# # #

About MarketPlace Logan, LLC
MarketPlace Logan, LLC, is an affiliate of New England Development and is the developer and manager of the Concessions Program at Boston Logan International Airport. Selected by the Massachusetts Port Authority, MarketPlace is responsible for developing, leasing, marketing and managing the Authority’s concessions program at Logan Airport with responsibility for overseeing the complete redevelopment and transformation of the concessions program.  The concessions program offers more than 150 shops, restaurants and services, including many local favorites and regional and national brands. For more information, visit

About MarketPlace Development:
MarketPlace Development, a New England Development company, develops and manages airport retail programs across the country.  A recognized industry leader for over 20 years, MarketPlace Development works in partnership with airports and airlines to enhance passenger satisfaction and maximize revenue. The Massachusetts-based company is responsible for the concession’s programs at Boston Logan International Airport, Philadelphia International Airport, Reagan National Airport, and Dulles International Airport, and has also worked with numerous airports and airlines across the country. Visit for more information.

About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading global health and wellness holding company. XpresSpa Group’s core asset, XpresSpa, is a leading airport retailer of spa services and related health and wellness products, with 50 locations in 25 airports globally. Through its XpresTest, Inc. subsidiary, the Company also provides COVID-19 screening and testing under its XpresCheck™ brand at JFK International Airport and Newark Liberty International Airport. To learn more about XpresSpa Group, visit: To learn more about XpresSpa, visit To learn more about XpresCheck, visit

Media Contact:

Jillian Tedeschi, Regan Communications

617-833-0507 (c),